Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association

LS Mehta, KE Watson, A Barac, TM Beckie, V Bittner… - Circulation, 2018 - Am Heart Assoc
Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many
people perceive breast cancer to be the number one threat to women's health. CVD and …

The impact of obesity on breast cancer diagnosis and treatment

K Lee, L Kruper, CM Dieli-Conwright… - Current oncology reports, 2019 - Springer
Abstract Purpose of Review Obesity is a recognized risk factor for the development of breast
cancer and recurrence even when patients are treated appropriately. We reviewed the …

[HTML][HTML] Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

G Curigliano, D Lenihan, M Fradley, S Ganatra… - Annals of …, 2020 - Elsevier
Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed
world. Evidence increasingly shows that these conditions are interlinked through common …

[HTML][HTML] Risk of cardiovascular disease in women with and without breast cancer: the pathways heart study

H Greenlee, C Iribarren, JS Rana… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
PURPOSE To examine cardiovascular disease (CVD) and mortality risk in women with
breast cancer (BC) by cancer therapy received relative to women without BC. METHODS …

Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from …

HL Brown, JJ Warner, E Gianos, M Gulati, AJ Hill… - Circulation, 2018 - Am Heart Assoc
In 2001, the Institute of Medicine (now known as the National Academy of Sci-ence)
published a seminal monograph, Exploring the Biological Contributions to Human Health …

Risk of death from cardiovascular disease following breast cancer: a systematic review

SAM Gernaat, PJ Ho, N Rijnberg, MJ Emaus… - Breast cancer research …, 2017 - Springer
Purpose Breast cancer incidence and survival is high, which results in high prevalence of
breast cancer survivors. The risk of (death from) cardiovascular disease (CVD) is higher in …

Comprehensive assessment of changes in left ventricular diastolic function with contemporary breast cancer therapy

JN Upshaw, B Finkelman, RA Hubbard… - JACC: Cardiovascular …, 2020 - jacc.org
Objectives: This study determined the effects of doxorubicin and/or trastuzumab on diastolic
function and the relationship between diastolic function and systolic dysfunction …

[HTML][HTML] Risk of cardiometabolic risk factors in women with and without a history of breast cancer: the pathways heart study

ML Kwan, RK Cheng, C Iribarren… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
PURPOSE The incidence of cardiometabolic risk factors in breast cancer (BC) survivors has
not been well described. Thus, we compared risk of hypertension, diabetes, and …

All-cause and cardiovascular disease mortality among breast cancer survivors in CLUE II, a long-standing community-based cohort

C Ramin, ML Schaeffer, Z Zheng… - JNCI: Journal of the …, 2021 - academic.oup.com
Background There is growing evidence that breast cancer survivors have higher
cardiovascular disease (CVD) mortality relative to the general population. Information on …

Cardiotoxicity and cardiac monitoring among chemotherapy-treated breast cancer patients

ML Henry, J Niu, N Zhang, SH Giordano… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: This study sought to determine the rate of chemotherapy-related cardiotoxicity
and to estimate adherence to recommendations for cardiac monitoring among breast cancer …